University of California-San Diego Medical Center

San Diego, California 92123

4 studies enrolling now · 70 studies all time

What they study most

ALS, Acute Decompensated Heart Failure, Acute Kidney Injury, Advanced Cancer, Advanced Liver Cancers, Alzheimer's Disease, Alzheimer's Disease Dementia, Amyotrophic Lateral Sclerosis, Anhedonia, Anxiety, Arrhythmias, Cardiac, Atrial Fibrillation

Studies at this site

• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients — Recruiting now
• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver) — Recruiting now
• Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS — Recruiting now
• Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS — Recruiting now
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
• MIP Versus PCNL for Kidney Stone Disease — Completed
• Emergency Medicine Palliative Care Access — Completed
• Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis — Completed
• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation — Completed
• Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury — Completed
• Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options — Completed
• Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study — Completed
• Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI) — Withdrawn before enrolling
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis — Completed
• Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment — Completed
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity — Completed
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis — Completed
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• A Study of CK-1827452 Infusion in Stable Heart Failure — Completed
• A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) — Completed
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder — Completed
• Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation. — Completed
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer — Completed
• Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis — Completed
• A Safety & Efficacy Study With Deep Transcranial Magnetic Stimulation for the Treatment of Post-Traumatic Stress Disorder (PTSD) — Stopped early
• Stannsoporfin With Light Therapy for Newborn Babies With Jaundice — Completed
• Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR) — Completed
• Methodology Study of Novel Outcome Measures to Assess Progression of ALS — Completed
• Use of Blended Oxygen for Delivery Room Resuscitation of Very Low Birth Weight Infants — Completed
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) — Completed
• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis — Completed
• The Maintenance of Human Atrial Fibrillation — Completed
• Antibiotic Safety (SCAMP) — Completed
• Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass — Completed
• Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transvaginal Ventral Hernia Repair — Status unconfirmed
• Guiding Evidence Based Therapy Using Biomarker Intensified Treatment — Stopped early
• Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia — Completed
• A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer — Completed
• Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates — Completed
• A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE) — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Treatment of Hemodialysis Catheter-Related Bacteremia — Withdrawn before enrolling
• Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) — Completed